The Trulicity pen -- an injectable drug for patients to manage their type 2 diabetes -- has been around for quite some time.

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

But Ozempic (semaglutide) is a weekly injection, and has also demonstrated superior efficacy to Trulicity in head-to-head trials. The Novo Nordisk drug was compared to Trulicity in its SUSTAIN 7 ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday.